flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 ADA 24: Trial: in Patients Treated with FLOWing with the SemagluTIDE —

When there's something really wrong with a published study, the journal can retract it, much like a carmaker recalling a flawed automobile

Ali A, Bain S, Hicks D, Newland Jones P, Patel DC, Evans M, et al

It remains an investigational compound undergoing Phase 3 testing and it is only sold privately When could it be approved

Some strong vitamin C drinks (like citrus juices) can slightly interfere if taken right together

It offers a low-cost trial starting at $0.50 for 7 to 14 days

Some researchers report that peptides reconstituted in sterile water degrade faster than those mixed with bacteriostatic water, even when stored at the same temperature